News
Tricylic agonist of cGAS/STING signaling tested by Curadev Pharma researchers May 26, 2025 ...
VENT-03 is the first oral small-molecule cyclic GMP-AMP synthase (cGAS) inhibitor to successfully complete a first-in-human Phase 1 study and was discovered using Ventus’ proprietary ReSOLVE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback